NCT04351633

Brief Summary

In the context of quarantine with COVID-19, we wish to study the experience and psychological impact in adult patients living with osteoporosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 15, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 17, 2020

Completed
6 days until next milestone

Study Start

First participant enrolled

April 23, 2020

Completed
7 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2020

Completed
Last Updated

December 11, 2020

Status Verified

May 1, 2020

Enrollment Period

7 days

First QC Date

April 15, 2020

Last Update Submit

December 10, 2020

Conditions

Sars-CoV2Osteoporosis

Keywords

Psychological impactCOVID-19

Outcome Measures

Primary Outcomes (1)

  • percentage of patient with feeling of disabilities

    maximum 1 week from baseline on

Study Arms (1)

osteoporosis patient

Other: questionnaire assesment

Interventions

questionnaire assesmentOTHER

questionnaire assesment

osteoporosis patient

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

osteoporosis patient will be interviewed par internet questionnaire (patient association / AFLAR)

You may qualify if:

  • Patient with osteoporosis
  • Patient in confinement
  • Patient with sufficient understanding of the French language

You may not qualify if:

  • Non adult patient
  • patient without quarantine

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital Roger Salengro, CHU Lille

Lille, 59037, France

Location

MeSH Terms

Conditions

OsteoporosisCOVID-19

Condition Hierarchy (Ancestors)

Bone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Bernard Cortet, MD,PhD

    University Hospital, Lille

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
FAMILY BASED
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 15, 2020

First Posted

April 17, 2020

Study Start

April 23, 2020

Primary Completion

April 30, 2020

Study Completion

April 30, 2020

Last Updated

December 11, 2020

Record last verified: 2020-05

Locations

FR(1)